Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh

Tuesday, August 23, 2011

More failed implanted hips are being reported to the FDA

This is a link to today's New York Times story . . . "Complaints Soar on Hip Implants"
Please join these patients:  contact your Representatives in DC and demand that the Charter of the FDA be updated from 1976 - which did not account for implants.  There is currently no effective "feedback loop" to the manufacturers to stop "innovations" that hurt patients and deplete our public and personal healthcare funds.

No comments:

Post a Comment